Comparing the sources of equine MSCs subjected to the induction medium, we observed that the gene expression of GFAP and S100β was significantly higher in equine AT-MSCs, which is the best candidate for cell-based therapy in the context of peripheral nerve injuries. Here, S100B is linked to peripheral nerve injury.